论文部分内容阅读
造血干细胞移植(HSCT)是一种有效的,有时是唯一的根治性治疗某些血液疾病的治疗方法。单倍型HSCT已在国际上实行约20余年,在过去的10年中,中国原创的非体外去T细胞单倍型移植体系为单倍型HSCT的改进做出突出贡献,使得HSCT实现人人都有供者。《中国肿瘤临床》2016年第24期“专家论坛”栏目特HSCTHSCT
Hematopoietic stem cell transplantation (HSCT) is an effective and sometimes the only cure for certain blood diseases. Haplotype HSCT has been practiced in the world for more than 20 years. In the past 10 years, China’s original off-vitro T-cell haplotype transplantation system made outstanding contributions to the improvement of haplotype HSCT, There are donors. “Chinese Oncology Clinical” 2016 the twenty-fourth period “expert forum ” section special HSCTHSCT